Erratum to: Obstetric antiphospholipid syndrome and long term arterial thrombosis risk (Journal of Thrombosis and Thrombolysis, (2017), 44, 3, (371-375), 10.1007/s11239-017-1526-9);Obstetric antiphospholipid syndrome and long term arterial thrombosis risk

Journal of Thrombosis and Thrombolysis

Volumn 44, Issue 3, 2017, Pages 371-375

  Drozdinsky, Genady ^a,b   Hadar, Eran ^a,b   Shmueli, Anat ^a,b   Gabbay Benziv, Rinat ^a,b   Shiber, Shachaf ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid syndrome; Obstetric; Stroke; Thrombosis

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; COMPLICATION; FEMALE; HUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PREGNANCY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; THROMBOSIS; TIME FACTOR; VEIN THROMBOSIS; YOUNG ADULT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 85026908682     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-017-1538-5     Document Type: Erratum

References (16)

1. Ruiz-Irastorza G, Crowther M, Khamashta M (2010) Antiphospholipid syndrome. Lancet 376(9751):1498–1509 DOI: 10.1016/S0140-6736(10)60709-X
2. Schreiber K, Hunt BJ (2016) Pregnancy and antiphospholipid syndrome. Semin Thromb Hemost 42(7):780–788 DOI: 10.1055/s-0036-1592336
3. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306 DOI: 10.1111/j.1538-7836.2006.01753.x
4. Simioni P (2012) Thrombosis risk in purely obstetric APS. Blood 119:2435–2436 DOI: 10.1182/blood-2012-01-398735
5. Barbhaiya M, Erkan D (2011) Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand? Curr Rheumatol Rep 13(1):59–69 DOI: 10.1007/s11926-010-0149-3
6. Finazzi G, Brancaccio V, Moia M, Ciaverella N, Mazzucconi MG, Schinco PC et al (1996) Natural history and risk factors for thrombosis in 360 patients with antiphopholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 100(5):530–536 DOI: 10.1016/S0002-9343(96)00060-5
7. Quenby S, Farquharson RG, Dawood F, Hughes AM, Topping J (2005) Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum Reprod 20(6):1729–1732 DOI: 10.1093/humrep/deh844
8. Gris JC, Bouvier S, Molinari N, Galanaud JP, Cochery-Nouvellon E, Mercier E et al (2012) Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood 119(11):2624–2632 DOI: 10.1182/blood-2011-09-381913
9. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Ed). Chest 133(6 suppl):844S–886S
10. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW (1994) Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 83:372–377
11. Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Lockshin MD (2001) High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 44(6):1466–1467 DOI: 10.1002/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C
12. Committee on Practice Bulletins—Obstetrics, American College of Obstetricians and Gynecologists (2012) Practice bulletin no. 132: antiphospholipid syndrome. Obstet Gynecol 120:1514 DOI: 10.1097/01.AOG.0000423816.39542.0f
13. Empson M, Lassere M, Craig JC, Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99:135
14. Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028–1039 DOI: 10.1002/art.20105
15. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case control study. Lancet 8(11):998–1005 DOI: 10.1016/S1474-4422(09)70239-X
16. Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT et al, (EUROAPS Study Group Collaborators) (2015) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases. Autoimmun Rev 14(5):387–395 DOI: 10.1016/j.autrev.2014.12.010